Lateral Flow Assay Development and the use of gold nanoparticles
November 1st, 2012
**This webinar was produced by Innova Biosciences which is now fully integrated with their company, Expedeon Ltd., and have taken the Expedeon Ltd name and logo.
This free webinar brings together three speakers with over 50 years’ experience in assay development, and provides a comprehensive introduction to the development of a lateral flow assay. Starting with the basic principles of antibody selection, reagents and early stage development, the webinar moves on to a discussion on the selection of materials, their properties and basic troubleshooting, and finally to the conjugation of antibodies to gold nanoparticles.
More about Lateral Flow Immunoassays
Since their introduction in the 1980s, lateral flow technologies have become important tools for point-of-care and home testing.
They are commonly used to detect a broad array of targets such as hCG (human chorionic gonadotropin), infectious diseases and drugs of abuse and are also commonplace in veterinary testing, environmental testing and for monitoring analytes related to the human physiological condition.
Initially tests provided a positive/negative result, but the development of reader technology and improvements in the materials and reagents has enabled a progression towards semi-quantitative and quantitative assays.
Lateral Flow Assay Development Services from Expedeon
Here at Expedeon we have a wealth of in-house expertise that can take your assay development from initial idea, through to R&D and then transfer to trusted partners for bulk manufacturing.
This full service is a multi-step project providing you with different options, from proof of principle LFA using a dipstick (with either spots or lines on the nitrocellulose membrane), to full strips with lines (or spots), sample pad, conjugate pad and absorbent pad.
Get your PDF copy